Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
57
ADPT Quote, Financials, Valuation and Earnings
Last price:
$17.79
Seasonality move
:
-17.94%
Day range:
$17.56 - $18.18
52-week range:
$6.26 - $20.76
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10.92x
P/B ratio:
13.47x
Volume:
1.9M
Avg. volume:
2.6M
1-year change:
197.2%
Market cap:
$2.8B
Revenue:
$179M
EPS (TTM):
-$0.54
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $98.4M | $154.3M | $185.3M | $170.3M | $179M | |
| Revenue Growth (YoY) | 15.65% | 56.88% | 20.06% | -8.11% | 5.1% | |
| Cost of Revenues | $22.5M | $63.3M | $78.8M | $97.8M | $82.4M | |
| Gross Profit | $75.9M | $91.1M | $106.5M | $72.5M | $96.6M | |
| Gross Profit Margin | 77.1% | 59.02% | 57.46% | 42.57% | 53.95% | |
| R&D Expenses | $116.1M | $130.1M | $121.8M | $101.6M | $94.3M | |
| Selling, General & Admin | $110.9M | $170M | $184.1M | $172.5M | $157.6M | |
| Other Inc / (Exp) | -- | -- | -- | -$25.4M | -$7.2M | |
| Operating Expenses | $228.7M | $300.1M | $304.6M | $274.1M | $249.9M | |
| Operating Income | -$152.8M | -$209M | -$198.2M | -$201.6M | -$153.3M | |
| Net Interest Expenses | -- | -- | $4.2M | $13.8M | $11.6M | |
| EBT. Incl. Unusual Items | -$146.2M | -$207.3M | -$200.4M | -$225.3M | -$159.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$146.2M | -$207.3M | -$200.4M | -$225.3M | -$159.6M | |
| Minority Interest in Earnings | -- | -$19K | -$177K | -$54K | -$103K | |
| Net Income to Common Excl Extra Items | -$146.2M | -$207.3M | -$200.4M | -$225.3M | -$159.6M | |
| Basic EPS (Cont. Ops) | -$1.11 | -$1.48 | -$1.40 | -$1.56 | -$1.08 | |
| Diluted EPS (Cont. Ops) | -$1.11 | -$1.48 | -$1.40 | -$1.56 | -$1.08 | |
| Weighted Average Basic Share | $131.2M | $140.4M | $142.5M | $144.4M | $147.1M | |
| Weighted Average Diluted Share | $131.2M | $140.4M | $142.5M | $144.4M | $147.1M | |
| EBITDA | -$144.3M | -$188M | -$170M | -$179.4M | -$134.1M | |
| EBIT | -$152.8M | -$209M | -$198.2M | -$201.6M | -$153.3M | |
| Revenue (Reported) | $98.4M | $154.3M | $185.3M | $170.3M | $179M | |
| Operating Income (Reported) | -$152.8M | -$209M | -$198.2M | -$201.6M | -$153.3M | |
| Operating Income (Adjusted) | -$152.8M | -$209M | -$198.2M | -$201.6M | -$153.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $39.5M | $47.8M | $37.9M | $46.4M | $94M | |
| Revenue Growth (YoY) | 50.07% | 21.19% | -20.72% | 22.46% | 102.38% | |
| Cost of Revenues | $18.1M | $20.3M | $25.1M | $19.1M | $21.3M | |
| Gross Profit | $21.3M | $27.5M | $12.8M | $27.3M | $72.6M | |
| Gross Profit Margin | 54.03% | 57.58% | 33.78% | 58.81% | 77.3% | |
| R&D Expenses | $32.5M | $30.7M | $23.2M | $22.1M | $20.9M | |
| Selling, General & Admin | $45.1M | $42.3M | $40.6M | $37.8M | $41.4M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $77.6M | $73M | $63.8M | $59.7M | $62.4M | |
| Operating Income | -$56.3M | -$45.4M | -$51M | -$32.4M | $10.3M | |
| Net Interest Expenses | -- | $653K | $3.7M | $2.9M | $3M | |
| EBT. Incl. Unusual Items | -$56M | -$45.3M | -$50.3M | -$32.1M | $9.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$56M | -$45.3M | -$50.3M | -$32.1M | $9.5M | |
| Minority Interest in Earnings | -$95K | -$38K | -$26K | -$26K | -$1K | |
| Net Income to Common Excl Extra Items | -$56M | -$45.3M | -$50.3M | -$32.1M | $9.5M | |
| Basic EPS (Cont. Ops) | -$0.40 | -$0.32 | -$0.35 | -$0.22 | $0.06 | |
| Diluted EPS (Cont. Ops) | -$0.40 | -$0.32 | -$0.35 | -$0.22 | $0.06 | |
| Weighted Average Basic Share | $140.8M | $142.9M | $144.7M | $147.5M | $152.4M | |
| Weighted Average Diluted Share | $140.8M | $142.9M | $144.7M | $147.5M | $163.2M | |
| EBITDA | -$50.6M | -$38.2M | -$43.3M | -$27.8M | $14.7M | |
| EBIT | -$56.3M | -$45.4M | -$51M | -$32.4M | $10.3M | |
| Revenue (Reported) | $39.5M | $47.8M | $37.9M | $46.4M | $94M | |
| Operating Income (Reported) | -$56.3M | -$45.4M | -$51M | -$32.4M | $10.3M | |
| Operating Income (Adjusted) | -$56.3M | -$45.4M | -$51M | -$32.4M | $10.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $146.6M | $168M | $179.7M | $177.3M | $252.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $53.1M | $76.2M | $94.7M | $87M | $82.9M | |
| Gross Profit | $93.5M | $91.9M | $85M | $90.3M | $169.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $133.3M | $126.4M | $104.2M | $96.8M | $85.2M | |
| Selling, General & Admin | $151.9M | $188M | $176M | $160.6M | $162.9M | |
| Other Inc / (Exp) | -- | -- | -- | -$7.2M | -- | |
| Operating Expenses | $285.2M | $314.5M | $280.2M | $256.5M | $248M | |
| Operating Income | -$191.6M | -$222.6M | -$195.2M | -$166.3M | -$78.1M | |
| Net Interest Expenses | -- | $653K | $14.4M | $11.6M | $11.8M | |
| EBT. Incl. Unusual Items | -$189.4M | -$221.6M | -$196M | -$195.3M | -$79.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.1M | -- | -- | -- | -- | |
| Net Income to Company | -$190.5M | -$221.6M | -$196M | -$195.3M | -$79.6M | |
| Minority Interest in Earnings | -$95K | -$60K | -$69K | -$104K | $17K | |
| Net Income to Common Excl Extra Items | -$190.5M | -$221.6M | -$196M | -$195.3M | -$79.6M | |
| Basic EPS (Cont. Ops) | -$1.37 | -$1.56 | -$1.36 | -$1.34 | -$0.53 | |
| Diluted EPS (Cont. Ops) | -$1.36 | -$1.56 | -$1.36 | -$1.34 | -$0.54 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$173.4M | -$194.9M | -$165.7M | -$146.1M | -$60M | |
| EBIT | -$191.6M | -$222.6M | -$195.2M | -$166.3M | -$78.1M | |
| Revenue (Reported) | $146.6M | $168M | $179.7M | $177.3M | $252.8M | |
| Operating Income (Reported) | -$191.6M | -$222.6M | -$195.2M | -$166.3M | -$78.1M | |
| Operating Income (Adjusted) | -$191.6M | -$222.6M | -$195.2M | -$166.3M | -$78.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $116.4M | $130.1M | $124.5M | $131.5M | $205.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $38.9M | $57M | $72.8M | $62M | $62.5M | |
| Gross Profit | $77.5M | $73.2M | $51.7M | $69.5M | $142.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $104.1M | $96.2M | $77.8M | $73.1M | $63.9M | |
| Selling, General & Admin | $119.9M | $138M | $129.9M | $117.9M | $123.2M | |
| Other Inc / (Exp) | -- | -- | -- | -$7.2M | -- | |
| Operating Expenses | $224.9M | $234.2M | $207.7M | $190.1M | $187.2M | |
| Operating Income | -$147.4M | -$161M | -$156M | -$120.6M | -$44.4M | |
| Net Interest Expenses | -- | $653K | $10.8M | $8.6M | $8.8M | |
| EBT. Incl. Unusual Items | -$145.9M | -$160.2M | -$155.8M | -$125.9M | -$45.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$145.9M | -$160.2M | -$155.8M | -$125.9M | -$45.9M | |
| Minority Interest in Earnings | -$95K | -$136K | -$28K | -$78K | $42K | |
| Net Income to Common Excl Extra Items | -$145.9M | -$160.2M | -$155.8M | -$125.9M | -$45.9M | |
| Basic EPS (Cont. Ops) | -$1.04 | -$1.13 | -$1.08 | -$0.86 | -$0.31 | |
| Diluted EPS (Cont. Ops) | -$1.04 | -$1.13 | -$1.08 | -$0.86 | -$0.31 | |
| Weighted Average Basic Share | $420.2M | $427M | $432.6M | $440.7M | $453.7M | |
| Weighted Average Diluted Share | $420.2M | $427M | $432.6M | $440.7M | $464.4M | |
| EBITDA | -$136.1M | -$139.9M | -$133.6M | -$105.8M | -$30.7M | |
| EBIT | -$147.4M | -$161M | -$156M | -$120.6M | -$44.4M | |
| Revenue (Reported) | $116.4M | $130.1M | $124.5M | $131.5M | $205.3M | |
| Operating Income (Reported) | -$147.4M | -$161M | -$156M | -$120.6M | -$44.4M | |
| Operating Income (Adjusted) | -$147.4M | -$161M | -$156M | -$120.6M | -$44.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $123.4M | $353.1M | $498.2M | $346.4M | $222.3M | |
| Short Term Investments | $564.8M | $214M | $408.2M | $281.3M | $174.4M | |
| Accounts Receivable, Net | $10M | $17.4M | $40.1M | $38M | $41.7M | |
| Inventory | $14.1M | $19.3M | $14.5M | $14.4M | $8.4M | |
| Prepaid Expenses | $14.5M | -- | -- | -- | -- | |
| Other Current Assets | -- | $13M | $9.4M | $11.4M | $11.3M | |
| Total Current Assets | $726.9M | $402.7M | $562.1M | $410.2M | $283.8M | |
| Property Plant And Equipment | $139M | $172.9M | $164.2M | $120.3M | $94.4M | |
| Long-Term Investments | $118.5M | $219.3M | $2.4M | $2.9M | $36.6M | |
| Goodwill | $119M | $119M | $119M | $119M | $119M | |
| Other Intangibles | $10.2M | $8.5M | $6.8M | $5.1M | $3.4M | |
| Other Long-Term Assets | $2.7M | $3M | $4.5M | $6.5M | $5.2M | |
| Total Assets | $1.1B | $923.3M | $856.6M | $661.1M | $539.4M | |
| Accounts Payable | $3.2M | $3.3M | $8.1M | $7.7M | $7.3M | |
| Accrued Expenses | $11.4M | $9M | $12.2M | $8.5M | $8M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $3.5M | $5.1M | $9.2M | $9.4M | $10.2M | |
| Other Current Liabilities | -- | -- | -- | -- | $865K | |
| Total Current Liabilities | $105.2M | $113.8M | $109.8M | $88M | $98.1M | |
| Long-Term Debt | -- | $106.7M | $224.1M | $220M | $211.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $373.1M | $319.2M | $392.5M | $352.9M | $336.9M | |
| Common Stock | $14K | $14K | $14K | $14K | $14K | |
| Other Common Equity Adj | $893K | -$1.1M | -$4.1M | $215K | $166K | |
| Common Equity | $743.3M | $604M | $464.2M | $308.4M | $202.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $110K | -$67K | -$121K | -$224K | |
| Total Equity | $743.3M | $604.1M | $464.1M | $308.3M | $202.5M | |
| Total Liabilities and Equity | $1.1B | $923.3M | $856.6M | $661.1M | $539.4M | |
| Cash and Short Terms | $688.3M | $353.1M | $498.2M | $346.4M | $222.3M | |
| Total Debt | -- | $106.7M | $224.1M | $220M | $212.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $415M | $508.1M | $371.1M | $243.3M | $212.8M | |
| Short Term Investments | $292.6M | $290.5M | $282.4M | $205.2M | -- | |
| Accounts Receivable, Net | $17.1M | $26.5M | $31.2M | $40.8M | $44.8M | |
| Inventory | $18.2M | $17.3M | $19.5M | $12M | $9.9M | |
| Prepaid Expenses | $16.6M | $12.4M | -- | -- | -- | |
| Other Current Assets | -- | -- | $13.4M | $12.2M | -- | |
| Total Current Assets | $467M | $564.4M | $435.2M | $308.3M | $281.4M | |
| Property Plant And Equipment | $177.3M | $169.3M | $152M | $97.8M | $79.5M | |
| Long-Term Investments | $219.5M | $22.1M | $2.9M | $26.8M | $6.7M | |
| Goodwill | $119M | $119M | $119M | $119M | -- | |
| Other Intangibles | $9M | $7.3M | $5.6M | $3.9M | -- | |
| Other Long-Term Assets | $3M | $4.6M | $5.9M | $5.6M | -- | |
| Total Assets | $992.6M | $884.2M | $717.7M | $558.5M | $490.6M | |
| Accounts Payable | $8.3M | $4.2M | $4.5M | $7.4M | $10.3M | |
| Accrued Expenses | $17M | $10.7M | $10.2M | $6.1M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $5.1M | $8.5M | $9.5M | $10M | -- | |
| Other Current Liabilities | -- | -- | $3.2M | -- | -- | |
| Total Current Liabilities | $122.4M | $104M | $93.3M | $87.6M | $83.4M | |
| Long-Term Debt | $108M | $225.1M | $218.6M | $214.5M | $201.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $341.1M | $396.4M | $356M | $334.9M | $286.4M | |
| Common Stock | $14K | $14K | $14K | $14K | $15K | |
| Other Common Equity Adj | $7K | -$6M | -$250K | $497K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $34K | -$26K | -$95K | -$199K | -$182K | |
| Total Equity | $651.5M | $487.8M | $361.6M | $223.6M | $204.3M | |
| Total Liabilities and Equity | $992.6M | $884.2M | $717.7M | $558.5M | $490.6M | |
| Cash and Short Terms | $415M | $508.1M | $371.1M | $243.3M | $212.8M | |
| Total Debt | $113.2M | $225.1M | $221.7M | $214.5M | $204.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$146.2M | -$207.3M | -$200.4M | -$225.3M | -$159.6M | |
| Depreciation & Amoritzation | $8.5M | $21M | $28.1M | $29.2M | $19.3M | |
| Stock-Based Compensation | $24.8M | $43.3M | $55.5M | $62.9M | $53.6M | |
| Change in Accounts Receivable | $2.6M | -$7.4M | -$22.6M | $2M | -$3.7M | |
| Change in Inventories | -$5M | -$5.2M | $817K | -$2.8M | $5.4M | |
| Cash From Operations | -$149.7M | -$192.7M | -$183.9M | -$156.3M | -$95.2M | |
| Capital Expenditures | $18.8M | $61.7M | $16.3M | $10.7M | $3.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$117M | $181.2M | $2.9M | $129.6M | $77.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$321K | $429K | $124.4M | -- | -- | |
| Cash From Financing | $293.6M | $27.1M | $132.3M | $2.2M | $241K | |
| Beginning Cash (CF) | $98.7M | $139.1M | $90M | $65.1M | $47.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $26.9M | $15.6M | -$48.8M | -$24.4M | -$17.2M | |
| Ending Cash (CF) | $125.6M | $154.7M | $41.3M | $40.6M | $30.7M | |
| Levered Free Cash Flow | -$168.5M | -$254.5M | -$200.3M | -$167M | -$98.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$56M | -$45.3M | -$50.3M | -$32.1M | $9.5M | |
| Depreciation & Amoritzation | $5.3M | $7.2M | $7.6M | $4.6M | $4.4M | |
| Stock-Based Compensation | $11.6M | $14.1M | $15.3M | $13.5M | $13.3M | |
| Change in Accounts Receivable | -$2.9M | -$2.8M | $334K | -$5.2M | -$536K | |
| Change in Inventories | $381K | $72K | -$273K | $1.7M | -$1.3M | |
| Cash From Operations | -$43.4M | -$42.4M | -$46.7M | -$27.1M | -$7.1M | |
| Capital Expenditures | $14.6M | $5.4M | $2.8M | $344K | $409K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$21.3M | $58M | $26.1M | $5.3M | $17.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | $124.7M | -- | -- | -- | |
| Cash From Financing | $2.9M | $125.5M | $17K | $40K | $1.7M | |
| Beginning Cash (CF) | $122.4M | $217.6M | $88.7M | $38.1M | $55M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$61.8M | $141.1M | -$20.5M | -$21.7M | $11.8M | |
| Ending Cash (CF) | $60.6M | $358.7M | $68.2M | $16.3M | $66.9M | |
| Levered Free Cash Flow | -$58.1M | -$47.8M | -$49.5M | -$27.4M | -$7.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$190.5M | -$221.6M | -$196M | -$195.3M | -$79.6M | |
| Depreciation & Amoritzation | $17.8M | $27.7M | $29.4M | $21.6M | $18.1M | |
| Stock-Based Compensation | $38.6M | $53.1M | $61.6M | $56.3M | $51.6M | |
| Change in Accounts Receivable | -$5.3M | -$9.4M | -$4.7M | -$9.6M | -$4M | |
| Change in Inventories | -$7.5M | -$3.2M | -$3.8M | $6M | $2.4M | |
| Cash From Operations | -$178.7M | -$207.8M | -$159.4M | -$109.7M | -$60.5M | |
| Capital Expenditures | $61.9M | $23.1M | $11.9M | $4.9M | $2.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$226.1M | $167.7M | $28.9M | $58.9M | $68.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $429K | -- | -- | -- | -- | |
| Cash From Financing | $30.1M | $135.5M | $2.2M | $201K | $8.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$374.7M | $95.4M | -$128.4M | -$50.6M | $16.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$240.6M | -$230.8M | -$171.4M | -$114.5M | -$62.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$145.9M | -$160.2M | -$155.8M | -$125.9M | -$45.9M | |
| Depreciation & Amoritzation | $10.9M | $21.1M | $22.3M | $14.8M | $13.6M | |
| Stock-Based Compensation | $31.4M | $41.2M | $47.4M | $40.8M | $38.8M | |
| Change in Accounts Receivable | -$7.1M | -$9.1M | $8.8M | -$2.8M | -$3.1M | |
| Change in Inventories | -$4.2M | -$2.2M | -$6.8M | $2M | -$988K | |
| Cash From Operations | -$138.9M | -$153.9M | -$129.4M | -$82.7M | -$48M | |
| Capital Expenditures | $52.5M | $13.8M | $9.4M | $3.6M | $2.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $114M | $100.4M | $126.4M | $55.7M | $46.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $429K | $124.7M | -- | -- | -- | |
| Cash From Financing | $23.9M | $132.3M | $2.2M | $114K | $8.7M | |
| Beginning Cash (CF) | $423.7M | $408.8M | $292.6M | $169.1M | $148.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1M | $78.8M | -$794K | -$26.9M | $6.9M | |
| Ending Cash (CF) | $422.7M | $487.6M | $291.8M | $142.2M | $155.7M | |
| Levered Free Cash Flow | -$191.4M | -$167.7M | -$138.8M | -$86.3M | -$50.4M | |
Get ADPT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ADPT
Sector
P/E ratio
--
23.89x
PEG ratio
-0.30x
-0.01x
P/B ratio
13.47x
1.82x
Price / LTM sales
10.92x
1.60x
Growth Metrics
ADPT
Sector
Revenue growth
102.38%
4.35%
Earnings growth
126.91%
9.95%
Revenue (5-year growth)
16.04%
6.41%
Earnings forecast
-$0.18
-$0.18
Profitability
ADPT
Sector
Profitability FY 2024
$96.6M
$3.4M
Return on invested capital
-18.96%
-32.69%
Return on assets
-15.33%
-29%
Return on equity
-39.8%
-38.43%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
10
Estimated Next Earnings Date
Feb
4
Balance Sheet
ADPT
Sector
Total cash
$212.8M
$25.7M
Short term investments
$174.4M
$25.5M
Total assets
$539.4M
$75.6M
Long term debt
$204.2M
$3.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Buy
53
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Buy
80
BNR alert for Jan 15
Burning Rock Biotech Ltd. [BNR] is up 18.69% over the past day.
Sell
37
TCOM alert for Jan 15
Trip.com Group Ltd. [TCOM] is down 2.31% over the past day.
Sell
39
DAVE alert for Jan 15
Dave, Inc. [DAVE] is up 3.48% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
